These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Vandergriff J, Rasmussen K. Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862 [Abstract] [Full Text] [Related]
3. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. Liechti ME, Markou A. Eur J Pharmacol; 2007 Jan 12; 554(2-3):164-74. PubMed ID: 17113075 [Abstract] [Full Text] [Related]
4. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Rasmussen K, Kendrick WT, Kogan JH, Aghajanian GK. Neuropsychopharmacology; 1996 Nov 12; 15(5):497-505. PubMed ID: 8914123 [Abstract] [Full Text] [Related]
5. The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal. Rasmussen K, Vandergriff J. Neuropharmacology; 2003 Jan 12; 44(1):88-92. PubMed ID: 12559125 [Abstract] [Full Text] [Related]
6. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus. Hong M, Milne B, Jhamandas K. Brain Res; 1993 Sep 24; 623(1):131-41. PubMed ID: 8221081 [Abstract] [Full Text] [Related]
7. Local opiate withdrawal in locus coeruleus neurons in vitro. Ivanov A, Aston-Jones G. J Neurophysiol; 2001 Jun 24; 85(6):2388-97. PubMed ID: 11387385 [Abstract] [Full Text] [Related]
8. The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy. Ngomba RT, Biagioni F, Casciato S, Willems-van Bree E, Battaglia G, Bruno V, Nicoletti F, van Luijtelaar EL. Neuropharmacology; 2005 Jun 24; 49 Suppl 1():89-103. PubMed ID: 16043198 [Abstract] [Full Text] [Related]
10. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats. Azizi H, Mirnajafi-Zadeh J, Rohampour K, Semnanian S. Neurosci Lett; 2010 Oct 04; 482(3):255-9. PubMed ID: 20667500 [Abstract] [Full Text] [Related]
11. Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats. Yoon MH, Choi Jl, Bae HB, Kim SJ, Chung ST, Jeong SW, Chung SS, Yoo KY, Jeong CY. Neurosci Lett; 2006 Feb 20; 394(3):222-6. PubMed ID: 16293369 [Abstract] [Full Text] [Related]
12. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. Homayoun H, Jackson ME, Moghaddam B. J Neurophysiol; 2005 Apr 20; 93(4):1989-2001. PubMed ID: 15590730 [Abstract] [Full Text] [Related]
13. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats. Feinberg I, Schoepp DD, Hsieh KC, Darchia N, Campbell IG. J Pharmacol Exp Ther; 2005 Feb 20; 312(2):826-33. PubMed ID: 15383637 [Abstract] [Full Text] [Related]
14. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats. Rasmussen K, Martin H, Berger JE, Seager MA. Neuropharmacology; 2005 Feb 20; 48(2):173-80. PubMed ID: 15695156 [Abstract] [Full Text] [Related]
15. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. Caillé S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L. J Pharmacol Exp Ther; 1999 Aug 20; 290(2):881-92. PubMed ID: 10411605 [Abstract] [Full Text] [Related]
16. Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495. Linden AM, Johnson BG, Trokovic N, Korpi ER, Schoepp DD. Neuropharmacology; 2009 Aug 20; 57(2):172-82. PubMed ID: 19477188 [Abstract] [Full Text] [Related]
17. Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus. Medrano MC, Mendiguren A, Pineda J. Psychopharmacology (Berl); 2015 Aug 20; 232(15):2795-809. PubMed ID: 25787747 [Abstract] [Full Text] [Related]
18. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Arcella A, Carpinelli G, Battaglia G, D'Onofrio M, Santoro F, Ngomba RT, Bruno V, Casolini P, Giangaspero F, Nicoletti F. Neuro Oncol; 2005 Jul 20; 7(3):236-45. PubMed ID: 16053698 [Abstract] [Full Text] [Related]
19. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK. J Pharmacol Exp Ther; 2000 Jan 20; 292(1):76-87. PubMed ID: 10604933 [Abstract] [Full Text] [Related]
20. Excitatory amino acid receptors are involved in morphine-induced synchronous oscillatory discharges in the locus coeruleus of rats. Zhu H, Zhou W. Eur J Pharmacol; 2005 Dec 28; 528(1-3):73-8. PubMed ID: 16316646 [Abstract] [Full Text] [Related] Page: [Next] [New Search]